CTS (Therapeutic Devices) Overview

  • Founded

  • 1997

Founded
  • Status

  • Out of Business

  • Employees

  • 3

Employees
  • Latest Deal Type

  • Out of Business

CTS (Therapeutic Devices) General Information

Description

Developer of a molecular imaging platform designed to detect cancer. The company's platform develops clinical products for cancer imaging and therapeutics and its core proprietary technology is based on gene which are specifically triggered inside cancer cells which are based on cell-specific gene promoters, enabling patients to detect early-stage cancer and start treatment according to it and also can be freeze-dried for long-term storage without losing efficacy and rapidly reconstituted for easy administration.

Contact Information

Website
www.cts-bioscience.com
Ownership Status
Out of Business
Financing Status
Formerly PE-Backed
Primary Industry
Therapeutic Devices
Other Industries
Biotechnology
Diagnostic Equipment
Primary Office
  • The Mansion
  • Chesterford Research Park
  • Cambridge CB10 1XL
  • England, United Kingdom
+44 01799 000000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CTS (Therapeutic Devices) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business 01-Apr-2019 00.00 Completed Out of Business
2. PE Growth/Expansion 17-Sep-2014 00.00 00.00 Completed Generating Revenue
1. Accelerator/Incubator Completed Startup
To view CTS (Therapeutic Devices)’s complete valuation and funding history, request access »

CTS (Therapeutic Devices) Patents

  • 3

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 000

    Granted

  • 1

    Pending

  • 000

    Expiring in next 12 mo

CTS (Therapeutic Devices) Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3781130-A4 Therapeutic constructs for treating cancer Pending 11-Apr-2018 000000000
EP-3781130-A1 Therapeutic constructs for treating cancer Pending 11-Apr-2018 000000000
US-20210154328-A1 Therapeutic constructs for treating cancer Pending 11-Apr-2018 C12N15/85

CTS (Therapeutic Devices) Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial